Min Fang, Taobo Luo, Yongling Ji, Jian Zeng. "Neoadjuvant hypofractionated radiotherapy plus tislelizumab with anlotinib followed by adjuvant tislelizumab with anlotinib in patients with resectable non-small cell lung cancer (NSCLC): Preliminary analysis of a phase II trial (NEO-PIONEER).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8063